Advisors Preferred LLC Takes Position in Centene Corporation $CNC

Advisors Preferred LLC purchased a new position in Centene Corporation (NYSE:CNC) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 15,764 shares of the company’s stock, valued at approximately $563,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. WPG Advisers LLC grew its stake in Centene by 44.5% in the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after acquiring an additional 282 shares in the last quarter. Versant Capital Management Inc raised its stake in shares of Centene by 11.6% during the third quarter. Versant Capital Management Inc now owns 3,421 shares of the company’s stock valued at $122,000 after acquiring an additional 355 shares in the last quarter. Snowden Capital Advisors LLC boosted its holdings in shares of Centene by 8.0% in the second quarter. Snowden Capital Advisors LLC now owns 5,073 shares of the company’s stock valued at $275,000 after purchasing an additional 374 shares during the period. Financial Network Wealth Advisors LLC increased its holdings in Centene by 54.9% during the 3rd quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock worth $39,000 after purchasing an additional 390 shares during the period. Finally, Geneos Wealth Management Inc. raised its position in Centene by 29.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 1,897 shares of the company’s stock valued at $103,000 after purchasing an additional 435 shares in the last quarter. Institutional investors own 93.63% of the company’s stock.

Centene Stock Performance

CNC stock opened at $43.21 on Friday. Centene Corporation has a one year low of $25.08 and a one year high of $66.03. The firm has a market cap of $21.25 billion, a price-to-earnings ratio of -3.17, a PEG ratio of 0.96 and a beta of 0.48. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.08 and a current ratio of 1.10. The firm has a 50-day simple moving average of $42.44 and a two-hundred day simple moving average of $36.94.

Centene (NYSE:CNC) last posted its quarterly earnings data on Friday, February 6th. The company reported ($1.19) EPS for the quarter, topping the consensus estimate of ($1.22) by $0.03. The firm had revenue of $49.73 billion during the quarter, compared to analyst estimates of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. Centene’s revenue was up 21.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.80 EPS. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. On average, equities analysts forecast that Centene Corporation will post 6.86 EPS for the current fiscal year.

Wall Street Analyst Weigh In

CNC has been the topic of a number of recent research reports. Wells Fargo & Company set a $44.00 price target on Centene and gave the stock an “equal weight” rating in a research report on Wednesday. Mizuho set a $47.00 target price on shares of Centene in a report on Friday, January 9th. Jefferies Financial Group cut their target price on shares of Centene from $43.00 to $37.00 and set a “hold” rating on the stock in a research report on Friday, February 13th. Truist Financial upped their price target on shares of Centene from $45.00 to $47.00 and gave the stock a “buy” rating in a research report on Monday, January 5th. Finally, Robert W. Baird lifted their price objective on shares of Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $41.88.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.